A single-center, cross-sectional study comparing antibody responses after mRNA-based vaccine between healthy controls and Behcet's syndrome
Latest Information Update: 19 Sep 2022
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 01 Oct 2022 Results published in the Rheumatology International
- 19 Sep 2022 New trial record